Covered recipient · General Payments record
ROBERT M BLUM
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2024
$2,208.72
- Reported across 120 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $319.42 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Corium, Inc. | $75.86 | 3 |
| ALK-Abello, Inc | $58.23 | 3 |
| Cranial Technologies, Inc | $37.22 | 2 |
| Merck Sharp & Dohme Corporation | $35.58 | 2 |
| Tris Pharma Inc | $32.51 | 2 |
| Gilead Sciences, Inc. | $29.67 | 1 |
| Verrica Pharmaceuticals Inc. | $21.08 | 1 |
| SANOFI PASTEUR INC. | $15.25 | 1 |
| Alexion Pharmaceuticals, Inc. | $14.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $14.02 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093918450 | CMS |
| ALK-Abello, Inc | $17.58 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099889183 | CMS |
| ALK-Abello, Inc | $20.98 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099889187 | CMS |
| ALK-Abello, Inc | $19.67 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099889185 | CMS |
| Corium, LLC | $23.42 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100087364 | CMS |
| Corium, LLC | $28.16 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100197760 | CMS |
| Corium, LLC | $24.28 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100189893 | CMS |
| Cranial Technologies, Inc | $19.60 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082224628 | CMS |
| Cranial Technologies, Inc | $17.62 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082224626 | CMS |
| Gilead Sciences, Inc. | $29.67 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133643730 | CMS |
| Merck Sharp & Dohme LLC | $16.27 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141917183 | CMS |
| Merck Sharp & Dohme LLC | $19.31 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141955209 | CMS |
| SANOFI PASTEUR INC. | $15.25 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128735176 | CMS |
| Tris Pharma Inc | $14.69 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147224568 | CMS |
| Tris Pharma Inc | $17.82 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147224570 | CMS |
| Verrica Pharmaceuticals Inc. | $21.08 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118378178 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.